Chartreusin sodium
| Code | Size | Price |
|---|
| TAR-T30870-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Chartreusin sodium is a biochemical.
CAS:
1393-72-2
Formula:
C32H31NaO14
Molecular Weight:
662.576
Purity:
0.98
SMILES:
[Na+].COC1C(O)C(C)OC(OC2C(Oc3cccc4c([O-])c5c6c(oc(=O)c7c(C)ccc(oc5=O)c67)c34)OC(C)C(O)C2O)C1O
References
1. Barcel? F, Cap? D, Portugal J. Thermodynamic characterization of the multivalent binding of chartreusin to DNA. Nucleic Acids Res. 2002 Oct 15;30(20):4567-73. PubMed PMID: 12384604; PubMed Central PMCID: PMC137122.
2. Poochikian GK, Cradock JC. Enhanced chartreusin solubility by hydroxybenzoate hydrotropy. J Pharm Sci. 1979 Jun;68(6):728-32. PubMed PMID: 458574.